Laura Kristin Newby MD, FACC, MHS

Dr. Newby is a Professor of Medicine in the Division of Cardiology and also serves as Co-Director of the Cardiac Care Unit at the Duke University Medical Center. She received her MD from the Indiana University School of Medicine and completed a residency in internal medicine and a cardiology fellowship at DUMC.

As a leader of several randomized clinical trials of new therapies and treatment strategies for acute coronary syndromes with DCRI coordinating center, Dr. Newby’s research interests include risk stratification and treatment of patients with acute and chronic coronary artery disease and systems issues for delivery of care to patients with these illnesses. She also has been the principal investigator of multiple studies assessing the use of novel protein biomarkers to enhance risk stratification and guide treatment selection in cardiovascular disease, and she is pursuing interests in the application of genomics for this purpose.

Dr. Newby acts as a co-investigator in the GeneQuest study of genetic associations with risk for early onset coronary disease as well as several ongoing projects exploring the use of RNA expression profiling, proteomics and metabolomics for risk stratification for coronary events. She is a member of the Steering Committee for the Duke CATHGEN biorepository collecting DNA, RNA and plasma from patients undergoing cardiac catheterization at Duke Hospital for use in ongoing and future genomic studies in cardiovascular disease.